(Q53364452)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

S Z Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

J I Fiechtner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

E A Tindall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

S D Dedhiya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

W W Zhao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

J T Osterhaus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

S S Yu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

Arthritis Care and Research

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

112-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

Rehabilitation advances in the treatment of arthritis and musculoskeletal disease.

21 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Renal complications of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Nonsteroidal anti-inflammatory drugs and antihypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Inhibition of platelet prostaglandin synthetase by oral aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Efficacy of Cyclosporin A in Rheumatoid Arthritis: Long-term Follow-up Data and the Effect on Quality of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

A comparison of disability measured by the Stanford Health Assessment Questionnaire disability scales (HAQ) in male and female rheumatoid outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Measurement of patient outcome in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Validity and discriminant ability of the HAQ Functional Index in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Are we making the most of the Stanford Health Assessment Questionnaire?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Use of the short form 36 (SF36) for health status measurement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

The dimensions of health outcomes: a cross-validated examination of health status measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

The measurement of health status and quality of life in rheumatological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Comparison of the Musculoskeletal Function Assessment Questionnaire with the Short Form-36, the Western Ontario and McMaster Universities Osteoarthritis Index, and the Sickness Impact Profile Health-Status Measures*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

What is the best way of assessing outcome after total knee replacement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Comparative measurement sensitivity of short and longer health status instruments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

A sharper Bonferroni procedure for multiple tests of significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200004%2913%3A2%3C112%3A%3AAID-ANR5%3E3.0.CO%3B2-L

10.1002/1529-0131(200004)13:2<112::AID-ANR5>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14635284%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference